I am a
Home I AM A Search Login

Papers of the Week

Papers: 19 Nov 2022 - 25 Nov 2022

2022 Nov 21

J Headache Pain



A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.


Yu S, Kim B-K, Wang H, Zhou J, Wan Q, Yu T, Lian Y, Arkuszewski M, Ecochard L, Wen S, Yin F, Li Z, Su W, Wang S-J
J Headache Pain. 2022 Nov 21; 23(1):146.
PMID: 36404301.


BACKGROUND: DRAGON was a phase 3, randomised, double-blind, placebo-controlled study which evaluated the efficacy and safety of erenumab in patients with chronic migraine (CM) from Asia not adequately represented in the global pivotal CM study.